ALK-Abelló A/S Stock price

Equities

ALK B

DK0061802139

Pharmaceuticals

Real-time Estimate Cboe Europe 10:14:35 2023-10-02 am EDT Intraday chart for ALK-Abelló A/S 5-day change 1st Jan Change
78.10 DKK -1.70% -5.00% -18.95%
Sales 2023 * 4,872 M 690 M Sales 2024 * 5,331 M 755 M Capitalization 17 573 M 2 489 M
Net income 2023 * 512 M 73 M Net income 2024 * 779 M 110 M EV / Sales 2023 *
3,63x
Net Debt 2023 * 110 M 16 M Net cash position 2024 * 618 M 88 M EV / Sales 2024 *
3,18x
P/E ratio 2023 *
33,6x
P/E ratio 2024 *
22,1x
Employees -
Yield 2023 *
2,10%
Yield 2024 *
3,15%
Free-Float58.99%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.06%
1 week-4.45%
1 month-4.39%
3 months+6.72%
6 months-25.12%
Current year-17.28%
More quotes
1 week
79.30
Extreme 79.3
82.10
1 month
74.50
Extreme 74.5
84.95
Current year
69.90
Extreme 69.9
113.40
1 year
69.90
Extreme 69.9
134.90
3 years
69.90
Extreme 69.9
175.00
5 years
44.05
Extreme 44.05
175.00
10 years
23.50
Extreme 23.5
175.00
More quotes
Date Price Change Volume
23-10-02 77.75 -2.14% 183 421
23-09-29 79.45 -0.06% 313,347
23-09-28 79.50 -0.87% 220,324
23-09-27 80.20 -0.25% 185,270
23-09-26 80.40 -1.89% 251,540

Delayed Quote Nasdaq Copenhagen, September 29, 2023 at 10:59 am EDT

More quotes
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company's allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
79.45DKK
Average target price
112.80DKK
Spread / Average Target
+41.98%
Consensus
  1. Markets
  2. Equities
  3. Stock ALK-Abelló A/S - Nasdaq Copenhagen
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer